Glioblastoma
📧 Sign up to get email alerts when something new happens for Glioblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-06-19Clinical Trial Update: Feasibility of ORGAnoids in Routine Clinical Practice for Molecular Analysis of the GLIOvascular Niche in Patients With Primary Brain Tumors. [NA]
This clinical trial update assesses the feasibility of using patient-derived organoids for routine molecular analysis of the gliovascular ni…
-
CLINICAL_TRIALS research · 2025-06-19Clinical Trial Update: Clinical Trial of BMS-986504 in Recurrent GBM Patients [EARLY_Phase 1]
An early-phase 1 clinical trial evaluating BMS-986504 in patients with recurrent glioblastoma (WHO Grade IV) is currently recruiting.
-
CLINICAL_TRIALS research · 2025-06-18Clinical Trial Update: Short Course Chemo-Radiation Therapy for Patients With Newly Diagnosed Glioblastoma [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial is evaluating a short-course chemo-radiation regimen for newly diagnosed glioblastoma; the study is current…
-
CLINICAL_TRIALS research · 2025-06-18Clinical Trial Update: Personalized Radiation Therapy for GBM [NA]
Ongoing trial update for personalized radiation therapy in glioblastoma, with the study currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-06-17Clinical Trial Update: SonoClear Acoustic Coupling Fluid (ACF) Mimicking Brain Tissue [NA]
SonoClear is reporting completion of its clinical trial evaluating Acoustic Coupling Fluid (ACF) for brain-tissue–mimicking use in condition…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: Anterior Temporal Lobectomy in Temporal Glioblastoma [Phase 3]
A Phase 3 clinical trial is evaluating anterior temporal lobectomy as a surgical treatment for newly diagnosed glioblastoma of the temporal …
-
CLINICAL_TRIALS trial_result · 2025-06-13Clinical Trial Update: Personalized Functional Profiling in Metastatic Gastrointestinal Cancer or Recurrent Glioblastoma Patients in Luxembourg. [NA]
Completed clinical trial investigating personalized functional profiling for patients with metastatic gastrointestinal cancer or recurrent g…
-
CLINICAL_TRIALS trial_result · 2025-06-12Clinical Trial Update: Safety of IMRT Treatment With Inhomogeneous Dose in Patients With Relapsed High-grade Gliomas. [NA]
A completed clinical trial evaluating the safety of intensity-modulated radiotherapy with an inhomogeneous dose in patients with relapsed hi…
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: Hitting the Mark: Introducing State-of-the-art MRI for Precision Radiotherapy of Glioblastoma [NA]
A clinical trial at Erasmus Medical Center is recruiting to evaluate a state-of-the-art MRI-guided precision radiotherapy approach for gliob…
-
CLINICAL_TRIALS trial_result · 2025-06-11Clinical Trial Update: Talazoparib - Carboplatin for Recurrent High-grade Glioma With DDRd [Phase 2]
Phase 2 trial evaluating talazoparib in combination with carboplatin for recurrent high-grade glioma with DDR deficiency has completed.
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Glutamate Excitotoxicity and Its Role in Glioblastoma Biology
A clinical trial investigating the role of glutamate excitotoxicity in glioblastoma biology is currently recruiting, sponsored by IRCCS San …
-
CLINICAL_TRIALS trial_result · 2025-06-10Clinical Trial Update: VB-111 in Surgically Accessible Recurrent/Progressive GBM [Phase 2]
Phase 2 trial of VB-111 in surgically accessible recurrent/progressive glioblastoma was terminated, with results posted in 2025.
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: Trial of Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide and BMX-001 [Phase 1, Phase 2]
This Phase 1/2 trial evaluating concurrent radiotherapy, temozolomide, and BMX-001 for newly diagnosed high-grade glioma has completed enrol…
-
CLINICAL_TRIALS other · 2025-06-08Clinical Trial Update: Radioimmunotherapy in Solid Tumors (PNRR-MCNT2-2023-12378239-Aim2) [NA]
A clinical trial update shows a radioimmunotherapy study for Glioblastoma is currently recruiting, sponsored by IRCCS San Raffaele.
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Regorafenib in Bevacizumab Refractory Recurrent Glioblastoma [Phase 2]
A Phase 2 trial evaluating regorafenib in bevacizumab-refractory recurrent glioblastoma has completed.
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Contribution of Cerebral 18F-DOPA PET-CT Scan in High-grade Recurrent Gliomas [NA]
A completed clinical trial evaluated the usefulness of cerebral 18F-DOPA PET-CT imaging in patients with recurrent high-grade glioma.
-
CLINICAL_TRIALS trial_result · 2025-06-04Clinical Trial Update: Tinostamustine With or Without Radiation Therapy in Treating Patients With Newly Diagnosed MGMT-Unmethylated Glioblastoma [Phase 1]
Phase 1 trial evaluating tinostamustine with or without radiation therapy in newly diagnosed MGMT-unmethylated glioblastoma; the study has c…
-
CLINICAL_TRIALS research · 2025-06-04Clinical Trial Update: Safety and Tolerability of Fb-PMT in Recurrent Glioblastoma [Phase 1]
Phase 1 study evaluating the safety and tolerability of Fb-PMT in patients with recurrent glioblastoma, with recruitment ongoing.
-
CLINICAL_TRIALS trial_result · 2025-06-03Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Immunogenicity of EGFR(V)-EDV-Dox in Subjects With Recurrent GBM [Phase 1]
A Phase 1 trial evaluating the safety, tolerability, and immunogenicity of EGFR(V)-EDV-Dox in subjects with recurrent glioblastoma and Grade…
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: DB107-Retroviral Replicating Vector (RRV) Combined With DB107-Flucytosine (FC) in Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma [Phase 2]
This entry describes a Phase 2 trial evaluating DB107-Retroviral Replicating Vector (RRV) in combination with DB107-Flucytosine for recurren…
-
CLINICAL_TRIALS other · 2025-05-28Clinical Trial Update: GRETeL: Tumor Response to Standard Radiotherapy and TMZ Patients With GBM
Duke University's GRETeL trial evaluating tumor response to standard radiotherapy and temozolomide in glioblastoma patients has been suspend…
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: Safety, Pharmacokinetics and Preliminary Efficacy of CS231295 in Advanced Solid Tumors [Phase 1]
A Phase 1 trial from Chipscreen Biosciences assesses safety, pharmacokinetics, and preliminary efficacy of CS231295 in adults with advanced …
-
CLINICAL_TRIALS trial_result · 2025-05-25Clinical Trial Update: Avelumab in Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 2]
A phase 2 trial of the anti-PD-L1 agent avelumab in newly diagnosed glioblastoma multiforme has completed enrollment and posted results.
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: Disulfiram/Copper Combination In The Treatment of Newly Diagnosed Glioblastoma Multiform [Phase 2]
This update describes a Phase 2 clinical trial evaluating a disulfiram/copper combination for newly diagnosed glioblastoma.
-
CLINICAL_TRIALS trial_result · 2025-05-22Clinical Trial Update: A Study Evaluating the Safety, Pharmacokinetic and Anti-tumor Activity of RO7428731 in Participants With Glioblastoma [Phase 1]
This entry summarizes the completion of a Phase 1 study evaluating the safety, pharmacokinetics, and anti-tumor activity of RO7428731 in pat…